SERPINI1 functions as a tumor suppressor in glioma.
Overview
- Suzhou Medical College of Soochow University, 199 Ren-Ai Road, Suzhou Industrial Park, Suzhou, 215123 Jiangsu China
- Department of Neurosurgery, Affiliated Hospital of Zunyi Medical University, No. 149 Dalian Road, Huichuan District, Zunyi, 563000 Guizhou China
- Department of Neurosurgery, Cancer Prevention and Treatment Institute of Chengdu, The Second Clinical Medical College, Chengdu Fifth People’s Hospital, Affiliated Fifth People’s Hospital of Chengdu University of Traditional Chinese Medicine), Chengdu, Sichuan China
- Center for Medicine Research and Translation, Chengdu Fifth People’s Hospital, Chengdu, Sichuan China
- The First People’s Hospital of Zunyi, Zunyi, Guizhou China
- Zunyi Medical University, Zunyi, Guizhou China
- Department of Neurosurgery, Southwest Hospital, Third Military Medical University (Army Medical University, Chongqing, China
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
The paper links to its data, not to its authors' code: see the Data section.
Tracing map
A tracing map links a paper to the code its authors published: this paper has none, so it has no map.
Data
Datasets cited
- geo:GSE108474, at NCBI GEO; found in the text, “Gene expression analysis”
Data availability statement
The paper has a data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it says that the data are available on request
Read it in the paper: doi.org/10.1038/s41598-026-55196-3.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 27 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 9 authors, 8 keywords, 12 MeSH terms, 2 funders, 32 references.
Cite
This paper
Luo, S., Du, C., Huang, Z., Wang, H., Chen, J., Han, C., Feng, H., Wang, P., & Yao, S. (2026). SERPINI1 functions as a tumor suppressor in glioma. Scientific reports, 16(1), 25172. https://
BibTeX
@article{luo2026serpini1
author = {Luo, Shuang and Du, Chenyan and Huang, Zhongmin and Wang, Hui and Chen, Jialin and Han, Chong and Feng, Hua and Wang, Peng and Yao, Shengtao},
title = {{SERPINI1 functions as a tumor suppressor in glioma}},
journal = {Scientific reports},
year = {2026},
month = jun,
volume = {16},
number = {1},
pages = {25172},
publisher = {Nature Publishing Group},
issn = {2045-2322},
doi = {10.1038/
url = {https://
pmid = {42230926},
pmcid = {PMC13470208}
}
RIS
TY - JOUR
AU - Luo, Shuang
AU - Du, Chenyan
AU - Huang, Zhongmin
AU - Wang, Hui
AU - Chen, Jialin
AU - Han, Chong
AU - Feng, Hua
AU - Wang, Peng
AU - Yao, Shengtao
TI - SERPINI1 functions as a tumor suppressor in glioma
T2 - Scientific reports
J2 - Sci Rep
PY - 2026
DA - 2026/
VL - 16
IS - 1
SP - 25172
SN - 2045-2322
PB - Nature Publishing Group
DO - 10.1038/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1038/
"type": "article-journal",
"title": "SERPINI1 functions as a tumor suppressor in glioma",
"container-title": "Scientific reports",
"author": [
{
"family": "Luo",
"given": "Shuang"
},
{
"family": "Du",
"given": "Chenyan"
},
{
"family": "Huang",
"given": "Zhongmin"
},
{
"family": "Wang",
"given": "Hui"
},
{
"family": "Chen",
"given": "Jialin"
},
{
"family": "Han",
"given": "Chong"
},
{
"family": "Feng",
"given": "Hua"
},
{
"family": "Wang",
"given": "Peng"
},
{
"family": "Yao",
"given": "Shengtao"
}
],
"container-title-short":
"volume": "16",
"issue": "1",
"page": "25172",
"DOI": "10.1038/
"PMID": "42230926",
"PMCID": "PMC13470208",
"ISSN": "2045-2322",
"publisher": "Nature Publishing Group",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
6,
2
]
]
}
}
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1186/s13293-026-00927-4 [code]
- Gene regulatory network analysis identifies dysregulation of hypoxia pathways as contributing to glioblastoma treatment resistance in females.Journal: Biology of sex differencesIn common: NCBI GEO GSE108474, other condition, cellular / molecular
- [2] doi:10.1016/j.isci.2026.115982 [code]
- Multi-omics profiling-derived signature links cellular ecosystem to glioblastoma prognosis.Journal: iScienceIn common: other condition, 3 references
- [3] doi:10.3390/cancers18132092
- TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activat
ed Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study. Journal: CancersIn common: other condition, 3 references - [4] doi:10.1186/s40478-026-02318-7
- Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation.Journal: Acta neuropathologica communicationsIn common: other condition, cellular / molecular, 2 references
- [5] doi:10.1038/s41467-026-74058-0
- IQGAP3 bridges matrix stiffness with glioma stem cell maintenance and radioresistance by stabilizing SOX2.Journal: Nature communicationsIn common: other condition, cellular / molecular, 2 references
- [6] doi:10.32604/or.2026.079221
- Single-Cell Sequencing Reveals the Heterogeneity of Glioma and Identifies IGFBP2 as A Potential Therapeutic Target.Journal: Oncology researchIn common: other condition, cellular / molecular, 2 references
- [7] doi:10.3390/ijms27167240
- 1-Piperidine Propionic Acid Inhibits PAR2/
SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness. Journal: International journal of molecular sciencesIn common: other condition, cellular / molecular, 2 references - [8] doi:10.1080/17501911.2026.2691031
- Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.Journal: EpigenomicsIn common: other condition, cellular / molecular, 2 references
- [9] doi:10.3390/biology15141179
- Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma.Journal: BiologyIn common: other condition, 2 references
- [10] doi:10.2147/ijgm.s605071
- Mendelian Randomization and Single-Cell RNA Sequencing Reveal CKAP4 and PFDN5 as Tumor Cell-Specific Causal Genes for Glioblastoma.Journal: International journal of general medicineIn common: other condition, cellular / molecular, 2 references
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Request its removal
To ask OSCR to remove this record, the copies of its authors' scripts or its tracing map, use the removal request page: signed in, you say who you are, what to remove and why, then review and confirm the request. Published rules decide every request (how).
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.
